80 related articles for article (PubMed ID: 21284766)
1. A novel oncoprotein Pirh2: rising from the shadow of MDM2.
Wang Z; Yang B; Dong L; Peng B; He X; Liu W
Cancer Sci; 2011 May; 102(5):909-17. PubMed ID: 21284766
[TBL] [Abstract][Full Text] [Related]
2. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.
Shloush J; Vlassov JE; Engson I; Duan S; Saridakis V; Dhe-Paganon S; Raught B; Sheng Y; Arrowsmith CH
J Biol Chem; 2011 Feb; 286(6):4796-808. PubMed ID: 21084285
[TBL] [Abstract][Full Text] [Related]
4. p53 ubiquitination: Mdm2 and beyond.
Brooks CL; Gu W
Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2.
Min SH; Kim DM; Heo YS; Kim HM; Kim IC; Yoo OJ
Life Sci; 2010 Jan; 86(1-2):66-72. PubMed ID: 19945467
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.
Corcoran CA; Montalbano J; Sun H; He Q; Huang Y; Sheikh MS
J Biol Chem; 2009 Aug; 284(33):21955-21970. PubMed ID: 19483087
[TBL] [Abstract][Full Text] [Related]
7. A newly identified Pirh2 substrate SCYL1-BP1 can bind to MDM2 and accelerate MDM2 self-ubiquitination.
Yan J; Zhang D; Di Y; Shi H; Rao H; Huo K
FEBS Lett; 2010 Aug; 584(15):3275-8. PubMed ID: 20598683
[TBL] [Abstract][Full Text] [Related]
8. Pirh2 RING-finger E3 ubiquitin ligase: its role in tumorigenesis and cancer therapy.
Jung YS; Qian Y; Chen X
FEBS Lett; 2012 May; 586(10):1397-402. PubMed ID: 22673504
[TBL] [Abstract][Full Text] [Related]
9. Identification of Pirh2E and Pirh2F, two additional novel isoforms of Pirh2 ubiquitin ligase from human hepatocellular liver carcinoma cell line.
Dong L; Liu Y; Qiu Y; Peng B; Yin J; Liu W; He X
Biomed Mater Eng; 2012; 22(1-3):89-95. PubMed ID: 22766706
[TBL] [Abstract][Full Text] [Related]
10. PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53.
Zheng G; Ning J; Yang YC
Biochem Biophys Res Commun; 2007 Dec; 364(2):344-50. PubMed ID: 17950244
[TBL] [Abstract][Full Text] [Related]
11. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.
Leng RP; Lin Y; Ma W; Wu H; Lemmers B; Chung S; Parant JM; Lozano G; Hakem R; Benchimol S
Cell; 2003 Mar; 112(6):779-91. PubMed ID: 12654245
[TBL] [Abstract][Full Text] [Related]
12. A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer.
Satija YK; Bhardwaj A; Das S
Int J Cancer; 2013 Dec; 133(12):2759-68. PubMed ID: 23436247
[TBL] [Abstract][Full Text] [Related]
13. Role of Pirh2 in mediating the regulation of p53 and c-Myc.
Hakem A; Bohgaki M; Lemmers B; Tai E; Salmena L; Matysiak-Zablocki E; Jung YS; Karaskova J; Kaustov L; Duan S; Madore J; Boutros P; Sheng Y; Chesi M; Bergsagel PL; Perez-Ordonez B; Mes-Masson AM; Penn L; Squire J; Chen X; Jurisica I; Arrowsmith C; Sanchez O; Benchimol S; Hakem R
PLoS Genet; 2011 Nov; 7(11):e1002360. PubMed ID: 22125490
[TBL] [Abstract][Full Text] [Related]
14. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
[TBL] [Abstract][Full Text] [Related]
15. Role of p53 circuitry in tumorigenesis: A brief review.
Niazi S; Purohit M; Niazi JH
Eur J Med Chem; 2018 Oct; 158():7-24. PubMed ID: 30199707
[TBL] [Abstract][Full Text] [Related]
16. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
[TBL] [Abstract][Full Text] [Related]
17. The Role of E3 Ligase Pirh2 in Disease.
Daks A; Fedorova O; Parfenyev S; Nevzorov I; Shuvalov O; Barlev NA
Cells; 2022 Apr; 11(9):. PubMed ID: 35563824
[TBL] [Abstract][Full Text] [Related]
18. Pirh2: an E3 ligase with central roles in the regulation of cell cycle, DNA damage response, and differentiation.
Halaby MJ; Hakem R; Hakem A
Cell Cycle; 2013 Sep; 12(17):2733-7. PubMed ID: 23966173
[TBL] [Abstract][Full Text] [Related]
19. Regulation of autophagy flux by E3 ubiquitin ligase Pirh2 in lung cancer.
Fedorova O; Gudovich A; Daks A; Baidyuk E; Shuvalov O; Petukhov A; Parfenyev S; Kizenko A; Barlev NA
Biochem Biophys Res Commun; 2021 Jul; 563():119-125. PubMed ID: 34090148
[TBL] [Abstract][Full Text] [Related]
20. The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase.
Daks A; Petukhov A; Fedorova O; Shuvalov O; Kizenko A; Tananykina E; Vasileva E; Semenov O; Bottrill A; Barlev N
Cell Death Dis; 2021 Jun; 12(6):581. PubMed ID: 34091597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
